← Evidence map

ReviewCancer treatment reviews2022

Beyond HER2: Targeting the ErbB receptor family in breast cancer.

Joshua Z Drago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35870237